If you went on a mission to find relief for your child’s fever or pain in September, you most likely discovered one of the most popular children’s pain relievers was missing from pharmacy shelves.
A legal fight between Panadol and Nurofen saw sales of the Children’s Panadol 1-5 years stopped as The Federal Court granted a temporary injunction against the syringe-based dosing device used with the Panadol suspension.
Parents are now being reassured that Children’s Panadol 1-5 years suspension is back to help relieve their little ones’ pain and fever.
Vincent Cotard, General Manager GSK Consumer Healthcare, said the last few weeks have seen an unprecedented number of calls from worried parents that the pain reliever that they are familiar with was not available.
“We hope the return of the product to the pharmacy shelf will alleviate any worries of our concerned customers.
“Children’s Panadol is an icon of the Australian medicine cabinet and has been trusted by generations to provide fast, effective and gentle pain relief for little ones from as young as one month.
“We sincerely thank all our valued consumers for their patience during this time and apologise for any inconvenience that may have been caused, Vincent Cotard said.”
Panadol has been rated Australia’s most trusted pain reliever brand for the 10th consecutive year in research released in July by Reader’s Digest.
Agree (0)
Disagree (
__small.png)
